IVFINVO Fertility, Inc. · NASDAQ Capital Market
Effective Supply — the real overhang

From what's tradeable today to what's realistically coming. Bigger = more selling pressure ahead.

2.20M
Reported Float
2.29M
Tradeable Now
(estimated float)
2.60M
Effective Supply
4.92M
Fully Diluted
Dilution risk8/10
CONFIDENCE: MEDIUM
HIGHAssessed Aug 5, 2026Trigger: EFFECT registration filingCRITICALELOC capacity vastly exceeding floatCRITICALFull-ratchet variable-rate convertible (related party)

Against a ~2.29M share float the company has just signed and registered a $15M (expandable to $50M) equity line with Alumni Capital covering 20,000,000 resale shares — roughly 873% of shares outstanding — priced at 94% of the lowest five-day VWAP (or 85% off-exchange), with the Nasdaq 19.99% exchange cap already waived by stockholders on 2026-07-23. That single mechanism awaits only S-1 effectiveness. Layered on top: a related-party JAG note ($287,333 principal, ~179,583 shares) and a 150,000-share JAG warrant that BOTH full-ratchet down to the price of any future lower-priced financing, meaning the first ELOC draw near $1.00 automatically resets them; 314,000 registered abeyance shares releasable on demand; and 1,893,492 warrants at $7.95 that are nominally 7.6x out of the money but carry adjustment-event provisions and sit with a counterparty that has been repriced-and-induced three times in eighteen months (Jan 2025 $1,008→$193.20, Apr 2025, Jan 2026 $8.45→$7.95). Score is held at 8 rather than 9-10 only because the ELOC is not yet drawable and the largest warrant slug is currently deep OTM at its stated strike.

Share Structure

Float to Fully Diluted Breakdown

LIKELY STALE

Reported float from Insight Sentry (NASDAQ:IVF) — reported float 2,332,829 against reported shares outstanding 2,349,035, price $1.05, market cap $2.47M. Adjusted based on SEC filing analysis.

Reported Float2.20M44.8%
Convertible Notes1.54M31.2%
JAG Notes (related party) as amended by JAG May 2026 Letter — conversion price resets to the price of ANY future lower-priced financing (full ratchet)
Conv. Price: variable
Est. Shares: ~180K (agent-computed)
Related-party demand promissory notes (CEO $110,000 / CBO-controlled entity $110,000) — non-convertible, 10% interest plus 10% financing fee, callable on 10 days notice
Conv. Price: unknown
Est. Shares: ~208K (estimate)
Decathlon Alpha V LP Revenue Loan (RSLA) — cash-pay, non-convertible
Conv. Price: fixed
Est. Shares: ~1.15M (estimate)
Warrants2.14M43.5%
common1.89M shares at $7.95
common150K shares at $1.6
common66K shares at $1.4898
placement_agent24K shares at $10.5625
common4K shares at $30
common61 shares at $14400
pre-funded0 shares
Other9K0.2%
Options / RSUs9K shares
≈ Estimated Actual Float

Reported float + filing adjustments

2.29M

MEDIUM confidence

Pending Shares as % of Float989%

Registered and convertible shares that could enter the float relative to current float size.

Fully Diluted4.92M100%

Share estimates are approximate. Convertible share counts based on current price. Review SEC filings for exact terms.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue
Dilution profile
Reverse splits (7)
  • 1-for-5·Mar 27, 2026~5 mo ago
  • 1-for-8·Nov 28, 2025~9 mo ago
  • 1-for-3·Jul 21, 2025~1 yr ago
  • 1-for-12·Mar 18, 2025~1 yr ago
  • 1-for-20·Jul 28, 2023~3 yr ago
  • 1:1.6·Nov 9, 2020~6 yr ago
  • 1-for-20·May 26, 2020~6 yr ago
Active mechanisms
  • Alumni Capital LP equity line of credit — $15,000,000 (expandable to $50,000,000) at 94% of lowest 5-day VWAP / 97% of prior-day low / 85% off-exchange; 20,000,000 shares registered on S-1 filed 2026-07-24, effectiveness pending
  • JAG Multi Investments convertible note — $287,333 principal at $1.60 with FULL RATCHET reset to any lower future financing price; ~179,583 shares
  • JAG May 2026 warrant — 150,000 shares at $1.60, exercise price resets to any lower future financing price
  • 314,000 registered shares held in abeyance under a 9.99% beneficial ownership blocker, issuable on holder instruction
  • 1,893,492 Armistice inducement warrants at $7.95, stockholder-approved 2026-07-23, subject to adjustment events and voluntary company repricing (a repricing/inducement has occurred three times in 18 months)
  • Series D Preferred (400 shares) convertible at $6.00 with weighted-average anti-dilution
  • Stockholder-approved Nasdaq 5635(d) authority (Proposal 6, 2026-07-23) for future below-market issuances of 20%+ of outstanding
  • 2019 Stock Incentive Plan increased to 1,000,000 shares (~20% of fully diluted) with 6% annual evergreen through 2029

Market Data

Price

$1.06

Market Cap

$2.66M

Outstanding

2.51M

Float

2.20M

Avg Volume

12.71M

Exchange: NASDAQ|Source: Insight Sentry
IVF Float & Dilution Analysis | ShareStructure.io